Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129


GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer.

Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, Song LB, Song M.

J Transl Med. 2012 Aug 20;10:168. doi: 10.1186/1479-5876-10-168.


Prognostic significance of Flotillin1 expression in clinically N0 tongue squamous cell cancer.

Li H, Zhang Y, Chen SW, Li FJ, Zhuang SM, Wang LP, Zhang J, Song M.

Int J Clin Exp Pathol. 2014 Feb 15;7(3):996-1003. eCollection 2014.


Upregulation of CENP-H in tongue cancer correlates with poor prognosis and progression.

Liao WT, Yu CP, Wu DH, Zhang L, Xu LH, Weng GX, Zeng MS, Song LB, Li JS.

J Exp Clin Cancer Res. 2009 Jun 5;28:74. doi: 10.1186/1756-9966-28-74.


Expression characteristics of astrocyte elevated gene-1 (AEG-1) in tongue carcinoma and its correlation with poor prognosis.

Ke ZF, He S, Li S, Luo D, Feng C, Zhou W.

Cancer Epidemiol. 2013 Apr;37(2):179-85. doi: 10.1016/j.canep.2012.10.007. Epub 2012 Nov 9.


Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.

Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, Chen K, Li J, Song L.

Clin Cancer Res. 2012 Aug 1;18(15):4059-69. doi: 10.1158/1078-0432.CCR-11-3156. Epub 2012 Jun 6.


Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis.

Zhou J, Xu T, Qin R, Yan Y, Chen C, Chen Y, Yu H, Xia C, Lu Y, Ding X, Wang Y, Cai X, Chen J.

J Neurooncol. 2012 Nov;110(2):195-203. doi: 10.1007/s11060-012-0970-9. Epub 2012 Sep 13.


High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.

Wang JH, Chen XT, Wen ZS, Zheng M, Deng JM, Wang MZ, Lin HX, Chen K, Li J, Yun JP, Luo RZ, Song LB.

PLoS One. 2012;7(10):e45622. doi: 10.1371/journal.pone.0045622. Epub 2012 Oct 2.


High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma.

Hu GS, Li YQ, Yang YM, Shi W, Liao AJ, Yao YH, Zeng B, Yuan J.

Tumour Biol. 2014 Sep;35(9):8625-32. doi: 10.1007/s13277-014-2105-8. Epub 2014 May 28.


Overexpression of GOLPH3 is associated with poor clinical outcome in gastric cancer.

Hu BS, Hu H, Zhu CY, Gu YL, Li JP.

Tumour Biol. 2013 Feb;34(1):515-20. doi: 10.1007/s13277-012-0576-z. Epub 2012 Nov 7.


High GOLPH3 expression is associated with a more aggressive behavior of epithelial ovarian carcinoma.

Ma Y, Ren Y, Zhang X, Lin L, Liu Y, Rong F, Wen W, Li F.

Virchows Arch. 2014 Apr;464(4):443-52. doi: 10.1007/s00428-014-1536-3. Epub 2014 Jan 24.


Overexpression of GOLPH3 is associated with poor prognosis and clinical progression in pancreatic ductal adenocarcinoma.

Zhang LJ, Wang KB, Liu LS, Chen LZ, Peng BG, Liang LJ, Li Z, Xue L, Li W, Xia JT.

BMC Cancer. 2014 Aug 7;14:571. doi: 10.1186/1471-2407-14-571.


Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.

Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, Fang L, Shen H.

Diagn Pathol. 2012 Sep 24;7:127. doi: 10.1186/1746-1596-7-127.


GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.

Xue Y, Wu G, Liao Y, Xiao G, Ma X, Zou X, Zhang G, Xiao R, Wang X, Liu Q, Long D, Yang J, Xu H, Liu F, Liu M, Xie K, Huang R.

Br J Cancer. 2014 Apr 29;110(9):2250-60. doi: 10.1038/bjc.2014.124. Epub 2014 Mar 4.


GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.

Wang Z, Jiang B, Chen L, Di J, Cui M, Liu M, Ma Y, Yang H, Xing J, Zhang C, Yao Z, Zhang N, Dong B, Ji J, Su X.

J Transl Med. 2014 Jan 21;12:15. doi: 10.1186/1479-5876-12-15.


Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.

Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M.

Clin Cancer Res. 2008 Jun 1;14(11):3319-26. doi: 10.1158/1078-0432.CCR-07-4054.


Overexpression of SIP1 and downregulation of E-cadherin predict delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma after partial glossectomy.

Sakamoto K, Imanishi Y, Tomita T, Shimoda M, Kameyama K, Shibata K, Sakai N, Ozawa H, Shigetomi S, Fujii R, Fujii M, Ogawa K.

Ann Surg Oncol. 2012 Feb;19(2):612-9. doi: 10.1245/s10434-011-2052-1. Epub 2011 Sep 13.


Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study.

Li XY, Liu W, Chen SF, Zhang LQ, Li XG, Wang LX.

J Neurooncol. 2011 Nov;105(2):159-63. doi: 10.1007/s11060-011-0573-x. Epub 2011 Apr 16.


Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.

Wang DD, Chen YB, Pan K, Wang W, Chen SP, Chen JG, Zhao JJ, Lv L, Pan QZ, Li YQ, Wang QJ, Huang LX, Ke ML, He J, Xia JC.

PLoS One. 2012;7(7):e40364. doi: 10.1371/journal.pone.0040364. Epub 2012 Jul 13.


Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.

Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, Li M, Zeng M, Zhou F, Song L.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2685-93. doi: 10.1158/1055-9965.EPI-09-0097. Epub 2009 Sep 15.


High GOLPH3 expression is associated with poor prognosis and invasion of hepatocellular carcinoma.

Li Q, Ma Y, Xu W.

Mol Med Rep. 2015 Jun;11(6):4315-20. doi: 10.3892/mmr.2015.3267. Epub 2015 Jan 28.

Items per page

Supplemental Content

Write to the Help Desk